Insider: Guyer William Chief Development Officer - CORCEPT THERAPEUTICS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 5,487 | 0 | 5,487 |
| Value | $458,521.16 | $0.00 | $458,521.16 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/02/2025 | DDS | 4,406 | Direct | COM | $70.85 | $312,155.41 | 5,487 |
| 09/02/2025 | DDS | 15,594 | Direct | COM | $70.39 | $1,097,692.85 | 9,893 |
| 08/08/2025 | DDS | 35,007 | Direct | COM | $71.77 | $2,512,452.39 | 5,487 |
| 08/05/2025 | DDS | 14 | Direct | COM | $71.77 | $1,004.78 | 5,487 |
| 07/18/2025 | DDS | 500 | Direct | COM | $73.44 | $36,721.00 | 5,487 |
| 07/17/2025 | DDS | 4,379 | Direct | COM | $73.48 | $321,773.74 | 5,487 |
| 07/01/2025 | DDS | 100 | Direct | COM | $73.51 | $7,350.50 | 5,487 |
| 06/10/2025 | DDS | 16,918 | Direct | COM | $72.36 | $1,224,260.92 | 8,569 |
| 06/10/2025 | DDS | 3,082 | Direct | COM | $72.75 | $224,213.65 | 5,487 |
| 05/16/2025 | DDS | 32,262 | Direct | COM | $74.17 | $2,393,014.49 | 5,487 |
| 05/06/2025 | DDS | 7,060 | Direct | COM | $74.31 | $524,652.60 | 5,487 |
| 04/01/2025 | DDS | 678 | Direct | COM | $114.51 | $77,639.00 | 5,487 |
| 03/04/2025 | DDS | 20,000 | Direct | COM | $59.07 | $1,181,400.00 | 5,487 |
| 11/04/2024 | DDS | 3,394 | Direct | COM | $48.97 | $166,204.18 | 5,796 |
| 11/01/2024 | DDS | 6,606 | Direct | COM | $48.97 | $323,495.82 | 5,796 |
| 10/01/2024 | DDS | 10,000 | Direct | COM | $46.28 | $462,800.00 | 5,796 |
| 09/03/2024 | DDS | 10,000 | Direct | COM | $35.30 | $353,000.00 | 6,039 |
| 08/01/2024 | DDS | 10,000 | Direct | COM | $38.67 | $386,700.00 | 6,039 |
| 07/01/2024 | DDS | 10,000 | Direct | COM | $32.49 | $324,900.00 | 6,039 |
| 06/03/2024 | DDS | 10,000 | Direct | COM | $32.00 | $320,000.00 | 6,039 |
| 05/28/2024 | DDS | 30,000 | Direct | COM | $32.00 | $960,000.00 | 6,039 |
| 12/22/2023 | DDS | 10,000 | Direct | COM | $32.00 | $320,000.00 | 6,643 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research